Survival Analysis on Breast Cancer Incidences in Ikeja, Lagos Nigeria Using Kaplan Meier and Cox Proportional Hazard Techniques

Crossmark

Main Article Content


Abstract

This study investigates breast cancer survival outcomes in relation to treatment types, using retrospective data sourced from the Oncology Department at Lagos State University Teaching Hospital (LASUTH). Employing survival analysis techniques—specifically the Kaplan-Meier method for estimating survival probabilities and the Cox Proportional Hazards model to examine the influence of demographic factors—the study measured survival time from diagnosis to either death or the last known follow-up. The event of interest was the patient’s vital status. Results indicated that while breast cancer affects all genders, females are nearly twice as likely to be diagnosed as males. Age was also a significant determinant of survival, with older patients exhibiting a higher risk of mortality, as shown by increasing hazard ratios. These findings highlight the importance of early detection, particularly in younger individuals, as a critical strategy to enhance survival prospects.

Downloads

Download data is not yet available.

Citation Metrics & Similar Scopus Articles

Data source Crossref
0
citations
Citation counts are source-specific and may differ because database coverage, reference matching, and update schedules are different. Counts are not added together. Crossref values represent citation links registered and matched by Crossref.
Check Secondary Documents in Scopus
Open this article in Scopus, then check the Secondary documents tab. Use Manual Citation Fallback only for counts you have verified manually.
Open in Scopus
Similar Scopus Articles
Scopus
  1. Durairaj A.B. (2027)
    Integrated proteomic, bioinformatic and qRT-PCR analyses reveal ANXA2 and ENO1 as key molecular targets of Anisomeles malabarica in breast cancer
    Advances in Biomarker Sciences and Technology, 9(1), 101-111
  2. Roy K.R. (2027)
    miRNA-mRNA multi-omics integration in breast cancer staging
    Advances in Biomarker Sciences and Technology, 9(1), 70-82
  3. Fan Y. (2027)
    Correction: Copper-Based Targeted Nanocatalytic Therapeutics for Non-Small Cell Lung Cancer (Nano-Micro Letters, (2026), 18, 1, (152), 10.1007/s40820-025-01998-5)
    Nano Micro Letters, 19(1)

Article Details

How to Cite
M., A. O., A., A. D., O., A. E., & O., E. K. (2025). Survival Analysis on Breast Cancer Incidences in Ikeja, Lagos Nigeria Using Kaplan Meier and Cox Proportional Hazard Techniques. Journal of Multidisciplinary Science: MIKAILALSYS, 3(2), 657-668. https://doi.org/10.58578/mikailalsys.v3i2.5365

References

Breyer, J. Z., Wendland, E. M., Kops, N. L., Caleffi, M., & Hammes, L. S. Assessment of potential risk factors for breast cancer in a population in Southern Brazil. Springer Nature, 169(1), Retrieved June 21, (2018), Pp 121-131.

Diabate, M., Coquille, L., & Samson, A. Parameter estimation and treatment optimization in a stochastic model for immunotherapy of cancer. (2018).

Ferraz, O. R., & Moreira-Filho, C. D. Survival analysis of women with breast cancer: competing risk models.Brazil:University of Campinas, (2016).

Kaplan, E. L. & Meier, P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), (1958), Pp 457–481.

Pazvakawambwa, L., &Embula, S. P. (2017). Prevalence, trends and risk factors of Breast Cancer Mortality in Namibia: 2000-2015. Windhoek: The University of Namibia. Retrieved September 28, (2018).

Tin, T. S., Elwood, M. J., Brown, C., Sarfati, D., Campbell, I., Scott, N., Lawrenson, R. Ethnic disparities in breast cancer survival in New Zealand: which factors contribute? BioMed Central. Retrieved September 28, (2018).

Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet‐tieulent, J. & Jemal, A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), (2015), Pp 87–108.

Vanderpuye, V., Grover, S., Hammad, N., Poojaprabhakar, Simonds, H., Olopade, F., & Stefan, D. C. An update on the management of breast cancer in Africa. BioMed Central, (2017), Pp 8-12.